Barclays Maintains Underweight on Omega Healthcare Invts, Lowers Price Target to $48

Barclays analyst Richard Hightower has maintained an Underweight rating on Omega Healthcare Investments (NYSE: OHI) and has reduced the price target from $50 to $48.